Evidence map›Paper›PMID 20959415›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation.

Min Li, Yoshio Tanaka, Abderrahmane Alioua, Yong Wu, Rong Lu, Pallob Kundu, Enrique Sanchez-Pastor, Jure Marijic, Enrico Stefani, Ligia Toro

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. MitoBKThe Journal of physiology · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. MaxiK channel and cell signalling.Pflugers Archiv : European journal of physiology · 2014
    Review
  13. Review
  14. MitoBK(Ca) is encoded by the Kcnma1 gene, and a splicing sequence defines its mitochondrial location.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Min LiDepartment of Anesthesiology, and Brain Research Institute, University of California, Los Angeles, CA 90095, USA.
Yoshio Tanaka
Abderrahmane Alioua
Yong Wu
Rong Lu
Pallob Kundu
Enrique Sanchez-Pastor
Jure Marijic
Enrico Stefani
Ligia Toro
Howard Hughes Medical Institute · USUniversity of California, Los Angeles · USToho University · JP

Funding

Revealing Cardiovascular Stress Regulation beyond the Diffraction LimitR01HL088640 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI STEFANI, ENRICO · 2007 to 2011
$5.3M
STRUCTURAL DETERMINANTS OF K(CA) CHANNEL FUNCTIONR01HL054970 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORO DE STEFANI, LIGIA G. · 1995 to 2009
$3.2M
Novel interactions of Slo1 channel and Thromboxane A2 receptor in blood vesselsR01HL096740 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI STEFANI, ENRICO, TORO DE STEFANI, LIGIA G. · 2009 to 2010
$1.3M
NHLBI NIH HHS HL088640NHLBI NIH HHS HL096740NHLBI NIH HHS HL54970NHLBI NIH HHS R01 HL054970NHLBI NIH HHS R01 HL088640NHLBI NIH HHS R01 HL096740
6 · The paper itself

Abstract

Large conductance voltage- and calcium-activated potassium channels (MaxiK, BK(Ca)) are well known for sustaining cerebral and coronary arterial tone and for their linkage to vasodilator β-adrenergic receptors. However, how MaxiK channels are linked to counterbalancing vasoconstrictor receptors is unknown. Here, we show that vasopressive thromboxane A2 receptors (TP) can intimately couple with and inhibit MaxiK channels. Activation of the receptor with its agonist trans-inhibits MaxiK independently of G-protein activation. This unconventional mechanism is supported by independent lines of evidence: (i) inhibition of MaxiK current by thromboxane A2 mimetic, U46619, occurs even when G-protein activity is suppressed; (ii) MaxiK and TP physically associate and display a high degree of proximity; and (iii) Förster resonance energy transfer occurs between fluorescently labeled MaxiK and TP, supporting a direct interaction. The molecular mechanism of MaxiK-TP intimate interaction involves the receptor's first intracellular loop and C terminus, and it entails the voltage-sensing conduction cassette of MaxiK channel. Further, physiological evidence of MaxiK-TP physical interaction is given in human coronaries and rat aorta, and by confirming TP role (with antagonist SQ29,548) in the U46619-induced MaxiK inhibition in human coronaries. We propose that vasoconstrictor TP receptor and MaxiK-channel direct interaction facilitates G-protein-independent TP to MaxiK trans-inhibition, which would promote vasoconstriction.

Indexed as

15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAnimalsAortaBridged Bicyclo Compounds, HeterocyclicCoronary VesselsEnzyme ActivationFatty Acids, UnsaturatedGTP-Binding ProteinsHumansHydrazinesLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsProtein Structure, TertiaryRatsRats, Sprague-DawleyReceptors, Thromboxane A2, Prostaglandin H2Vasoconstriction15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidBridged Bicyclo Compounds, HeterocyclicFatty Acids, UnsaturatedGTP-Binding ProteinsHydrazinesKCNMA1 protein, humanKcnma1 protein, ratLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsReceptors, Thromboxane A2, Prostaglandin H2SQ 29548Vasoconstrictor Agents

Identifiers

PMID20959415
PMCPMC2973862
OpenAlexW2045233162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.